World CAB
3 articles
Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting
Bangkok, Thailand, 28 February 2014
Activists from 22 countries joined forces at the first-ever HCV World CAB to demand equitable access to HCV treatment from six multinational pharmaceutical companies. More
1st Hepatitis C Virus World Community Advisory Board Report
14 July 2014 - By Odilon Couzin and Karyn Kaplan
Treatment activists held the first global LMIC-focused dialogue with pharmaceutical companies that produce HCV treatment, co-organized by TAG and the Asia Pacific Network of PLHA. More
Forging a Path to HCV Elimination: Simpler Tests and Affordable Generics
Report of the World Community Advisory Board on HCV Generics and Diagnostics, 18-20 July 2017, Bangkok, Thailand
Treatment activists met with generics and diagnostics companies to present demands and obtain strategic information from companies on critical access issues in low- and middle-income countries. More
